Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (111-120 of 211) with videos related to

Pageof 22
Sort By:
Scientific Reports|April 26, 2017
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesDavid N O'Dwyer, Katy C Norman, Meng Xia, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2022
Genome-wide Enrichment of <i>TERT</i> Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino AncestryDavid Zhang, Gundula Povysil, Chad A Newton, et al.
BMC Pulmonary Medicine|March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L Todd, Richard Vinisko, Yi Liu, et al.
Chest|March 9, 2026
MMP12 Improves the Differentiation of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis and Associates with Antigen Response PathwaysSam B Konkol, Yong Huang, Shwu-Fan Ma, et al.
The European Respiratory Journal|August 17, 2023
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung diseaseDavid Zhang, Ayodeji Adegunsoye, Justin M Oldham, et al.
The European Respiratory Journal|May 5, 2018
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysisAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
The transcriptome of CD14 <sup>+</sup> CD163 <sup>-</sup> HLA-DR <sup>low</sup> monocytes predicts mortality in Idiopathic Pulmonary FibrosisTheodoros Karampitsakos, Bochra Tourki, Minxue Jia, et al.
Chest|October 22, 2023
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary FibrosisJohn S Kim, Shwu-Fan Ma, Jennie Z Ma, et al.
Chest|October 2, 2017
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease CohortAyodeji Adegunsoye, Justin M Oldham, Jonathan H Chung, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variantsRitah Nabunje, Beatriz Guillen-Guio, Tamara Hernandez-Beeftink, et al.
Pageof 22

Showing results (111-120 of 211) with videos related to

Sort By:
Pageof 22
Scientific Reports|April 26, 2017
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesDavid N O'Dwyer, Katy C Norman, Meng Xia, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2022
Genome-wide Enrichment of <i>TERT</i> Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino AncestryDavid Zhang, Gundula Povysil, Chad A Newton, et al.
BMC Pulmonary Medicine|March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L Todd, Richard Vinisko, Yi Liu, et al.
Chest|March 9, 2026
MMP12 Improves the Differentiation of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis and Associates with Antigen Response PathwaysSam B Konkol, Yong Huang, Shwu-Fan Ma, et al.
The European Respiratory Journal|August 17, 2023
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung diseaseDavid Zhang, Ayodeji Adegunsoye, Justin M Oldham, et al.
The European Respiratory Journal|May 5, 2018
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysisAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
The transcriptome of CD14 <sup>+</sup> CD163 <sup>-</sup> HLA-DR <sup>low</sup> monocytes predicts mortality in Idiopathic Pulmonary FibrosisTheodoros Karampitsakos, Bochra Tourki, Minxue Jia, et al.
Chest|October 22, 2023
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary FibrosisJohn S Kim, Shwu-Fan Ma, Jennie Z Ma, et al.
Chest|October 2, 2017
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease CohortAyodeji Adegunsoye, Justin M Oldham, Jonathan H Chung, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variantsRitah Nabunje, Beatriz Guillen-Guio, Tamara Hernandez-Beeftink, et al.
Pageof 22